Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Children with vitiligo may have other health issues like skin, thyroid, and mental health problems.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Topical antibiotics successfully treated a rare scalp condition in an elderly man with vitiligo.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Vitiligo and alopecia should be covered by Medicaid and TRICARE as medical, not cosmetic, conditions.

Vitiligo's impact varies widely, affecting both emotions and social life, not just physical symptoms.

The study found that the most common repigmentation pattern in children with vitiligo is a combination of patterns, with a new medium spotted pattern identified.

Vitiligo often runs in families and is linked to genetics and autoimmune factors.

Vitiligo is not linked to coeliac disease, but a small number of alopecia areata patients may have it, suggesting they should be tested for coeliac disease.

Suplatast tosilate successfully treated a woman's systemic sclerosis symptoms.

Certain gene variations and different levels of BDNF and CRH hormones are linked to vitiligo.

Diphencyprone therapy for hair loss can cause vitiligo.

Vogt-Koyanagi syndrome often leads to partial or complete blindness and responds poorly to treatment.

Nonsegmental vitiligo is caused by the immune system attacking skin cells, often linked to other autoimmune diseases.

Low levels of BDNF and vitamin D are linked to higher depression in alopecia areata and vitiligo patients.

KLB and EIF3C genes are key for early diagnosis of vitiligo and alopecia areata.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

People often have negative attitudes towards facial skin conditions, with vitiligo seen most positively and psoriasis viewed most negatively.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

Platelet-rich plasma (PRP) may improve healing in chronic wounds and vitiligo and promote hair regrowth, but more research is needed.

The study suggests a link between varicella-zoster virus and segmental vitiligo, with evidence of the virus disrupting skin pigment cells.

Some people with the skin color loss condition, vitiligo, also develop the skin inflammation condition, lichen planus, possibly due to local trauma, sun damage, or genetic factors.

Type 1 diabetes patients often have other autoimmune diseases, which complicate their care.

People with vitiligo tend to have lower vitamin D levels.

Regular lab tests and follow-ups are important for managing vitiligo, especially checking thyroid antibodies.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Many female medical students in Saudi Arabia show signs of insulin resistance linked to increased waist size.

Proper skin care and dermocosmetics improve skin issues in diabetes patients.